Evgen Pharma Plc (EVG):企業の財務・戦略的SWOT分析

◆英語タイトル:Evgen Pharma Plc (EVG) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH2347028FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥84,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥126,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Evgen Pharma Plc (Evgen Pharma), formerly Evgen Pharma Ltd is a clinical-stage drug development company. It is focused on the development of sulforaphane-based
compounds for the treatment of cancer and neurological disease. Its pipeline product SFX-01 targets STAT3 signalling to inhibit stem-like cells in breast cancer patient-derived xenograft tumors; and reduces the vasospasm and incidence of delayed cerebral ischemia which can lead to cognitive impairment in subarachnoid haemorrhage indications. Its clinical pipeline product is based on proprietary Sulforadex technology that synthesizes and concurrently stabilizes the naturally occurring compound such as sulforaphane. Evgen Pharma carries out preclinical work in multiple sclerosis and has clinical interest in prostate cancer. It has operations in Wilmslow, Liverpool and London, the UK. Evgen Pharma is headquartered in Wilmslow, the UK.

Evgen Pharma Plc Key Recent Developments

Mar 22,2021: Evgen Pharma: Appointment of Chief Business Officer
Dec 10,2020: Evgen Pharma: Half year report 2020
Sep 24,2020: Evgen Pharma announces appointment of chief executive officer
Sep 15,2020: Juvenescence Announces Licensing Agreement with Evgen Pharma PLC
Jun 15,2020: EVGEN PHARMA: Final Results

This comprehensive SWOT profile of Evgen Pharma Plc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Evgen Pharma Plc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Evgen Pharma Plc – Key Information
Evgen Pharma Plc – Overview
Evgen Pharma Plc – Key Employees
Evgen Pharma Plc – Key Employee Biographies
Evgen Pharma Plc – Key Operational Heads
Evgen Pharma Plc – Major Products and Services
Evgen Pharma Plc – History
Evgen Pharma Plc – Company Statement
Evgen Pharma Plc – Locations And Subsidiaries
Evgen Pharma Plc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Evgen Pharma Plc – Business Description
Evgen Pharma Plc – Corporate Strategy
Evgen Pharma Plc – SWOT Analysis
SWOT Analysis – Overview
Evgen Pharma Plc – Strengths
Evgen Pharma Plc – Weaknesses
Evgen Pharma Plc – Opportunities
Evgen Pharma Plc – Threats
Evgen Pharma Plc – Key Competitors

Section 3 – Company Financial Performance Charts

Evgen Pharma Plc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Evgen Pharma Plc, Key Information
Evgen Pharma Plc, Key Ratios
Evgen Pharma Plc, Share Data
Evgen Pharma Plc, Major Products and Services
Evgen Pharma Plc, History
Evgen Pharma Plc, Key Employees
Evgen Pharma Plc, Key Employee Biographies
Evgen Pharma Plc, Key Operational Heads
Evgen Pharma Plc, Other Locations
Evgen Pharma Plc, Subsidiaries
Evgen Pharma Plc, Key Competitors
Evgen Pharma Plc, SWOT Analysis
Evgen Pharma Plc, Ratios based on current share price
Evgen Pharma Plc, Annual Ratios
Evgen Pharma Plc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Evgen Pharma Plc (EVG):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • NuScale Power LLC:企業の戦略的SWOT分析
    NuScale Power LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • CEL-SCI Corp (CVM)-製薬・医療分野:企業M&A・提携分析
    Summary CEL-SCI Corp (CEL-SCI) is a biotechnology company that carries out the research and development of new immunotherapy products for the treatment of various cancer and infectious diseases. Its core capabilities include drug discovery, research, development and manufacturing of compound biologi …
  • Sabre Corporation (SABR):企業の財務・戦略的SWOT分析
    Sabre Corporation (SABR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • The Williams Companies Inc (WMB):企業の財務・戦略的SWOT分析
    The Williams Companies Inc (WMB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Oncolytics Biotech Inc (ONC)-製薬・医療分野:企業M&A・提携分析
    Summary Oncolytics Biotech Inc (Oncolytics) is a development stage biopharmaceutical company which focuses on the discovery and development of oncolytic viruses for the treatment of cancer. The company’s lead product, Reolysin, a formulation of the human reovirus, is at Phase II clinical trials indi …
  • Catalyst Paper Corporation:企業の戦略的SWOT分析
    Catalyst Paper Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Kenya Power and Lighting Co Ltd (KPLA):企業の財務・戦略的SWOT分析
    Kenya Power and Lighting Co Ltd (KPLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Grupo Biotoscana SL (GBIO33):製薬・医療:M&Aディール及び事業提携情報
    Summary Grupo Biotoscana SL (Biotoscana) is a biopharmaceutical company that develops, manufactures and markets advanced medicines for unmet medical needs. The company offers products such as vidaza, ladevina, zyvalix, mielozitidina, votrynib, bozob, timab, enzastar, capebina, leprid, olvestran, toc …
  • Summit Pharmaceuticals International Corp:企業の戦略的SWOT分析
    Summit Pharmaceuticals International Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Weight Watchers International, Inc.:企業の戦略・SWOT・財務情報
    Weight Watchers International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Weight Watchers International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Martin Mathew & Co. Ltd.:企業の戦略・SWOT・財務情報
    Martin Mathew & Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Martin Mathew & Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Attica Bank S.A.:企業の戦略・SWOT・財務分析
    Attica Bank S.A. - Strategy, SWOT and Corporate Finance Report Summary Attica Bank S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Luxottica Group S.p.A.:企業の戦略・SWOT・財務情報
    Luxottica Group S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Luxottica Group S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Trafigura Group Pte. Ltd.-石油・ガス分野:企業M&A・提携分析
    Summary Trafigura Group Pte. Ltd. (Trafigura), a subsidiary of Trafigura Beheer B.V., is an independent commodity trading and logistics company. Its operations include trading of physical commodities, shipping and chartering, and asset management. The company sources, stores, transports and delivers …
  • F. Hoffmann-La Roche Ltd:企業のM&A・事業提携・投資動向
    F. Hoffmann-La Roche Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's F. Hoffmann-La Roche Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Microsemi Corp:企業の戦略的SWOT分析
    Microsemi Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Stolt-Nielsen Ltd (SNI)-石油・ガス分野:企業M&A・提携分析
    Summary Stolt-Nielsen Ltd (Stolt-Nielsen) formerly Stolt-Nielsen S.A., is an integrated global transportation company, which provides bulk-liquid transportation, storage and distribution services. The company services include transportation of liquefied petroleum gas (LPG), terminal storage and dist …
  • Orange and Rockland Utilities, Inc.:企業の戦略的SWOT分析
    Orange and Rockland Utilities, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Ashley Furniture Industries Inc:企業の戦略・SWOT・財務分析
    Ashley Furniture Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Ashley Furniture Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • NIH Office of Technology Transfer-製薬・医療分野:企業M&A・提携分析
    Summary NIH Office of Technology Transfer (NIH OTT), a subsidiary of National Institutes of Health is a healthcare service provider that evaluates, protects, markets, licenses, monitors, and manages NIH and FDA discoveries, inventions, and other intellectual property. The center discovers new biolog …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆